Testing Options

ClearID blood tests offer a solution where traditional tissue biopsies may fall short. By targeting and analyzing genes that are known to be associated with cancer, ClearID can help inform treatment decisions so doctors can match patients with clinical trials that fit their specific genetic profile.

Currently available tests are listed below. Additional targeted oncogene panels are in development. Cynvenio's unique approach to liquid biopsy includes the analysis of circulating tumor cells, cell-free DNA and germline DNA, allowing for a major differentiation between our tests and tests currently offered in the liquid biopsy space.

Request Information

Name *
I would like information about: *
/*This is to open gallery links in new window*/